Home › Borstkanker › Pennsylvania › Pittsburgh
Borstkanker klinische studies in Pittsburgh, PA
39 studies voor Borstkanker zoeken deelnemers op locaties in en rond Pittsburgh (binnen ongeveer 30 mijl). Open een studie om te zien wie er kan deelnemen en hoe je contact opneemt met het studieteam.
Officiële studietekst (Engels)
Rekruteren voor een studie? Laat deze bovenaan deze pagina verschijnen — $99 voor 30 dagen →
The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
RekruterenFase 1/2
- University of Pittsburgh Medical Center, Pittsburgh
Phase IIIb Study of Ribociclib + ET in Early Breast Cancer
RekruterenFase 3
- Allegheny Health Network, Pittsburgh
Distance-Based Exercise to Preserve Function and Prevent Disability
Rekruteren
- UPMC Hillman Cancer Center, Pittsburgh
A Study of Alisertib in Combination With Endocrine Therapy in Patients With HR-positive, HER2-negative Recurrent or Metastatic Breast Cancer
RekruterenFase 2
- University of Pittsburgh (UPMC), Pittsburgh
Prospective Study of EXErcise Regimens After Treatment for Breast Cancer for Hypertrophy and Conditioning
RekruterenObservatieonderzoek
- Allegheny General Hospital, Pittsburgh
A Pilot Study Assessing Myokines During an EXErcise Regimen After Treatment for Breast Cancer
Rekruteren
- AHN Allegheny General Hospital, Pittsburgh
- Allegheny General Hospital, Pittsburgh
A Study of NT-175 in Adult Participants With Advanced Malignancies That Are Positive for HLA-A*02:01 and the TP53 R175H Mutation
RekruterenFase 1
- Research Site, Pittsburgh
EXERT-BC Protein: Protein Supplementation to Improve Body Composition After Treatment for Breast Cancer
Rekruteren
- AHN Allegheny General Hospital, Pittsburgh
- AHN Allegheny General Hospital, Pittsburgh
A Clinical Study of Patritumab Deruxtecan to Treat Breast Cancer (MK-1022-016)
RekruterenFase 3
- University of Pittsburgh Medical Center Magee-Womens Hospital ( Site 0058), Pittsburgh
Multicenter Trial for Eliminating Breast Cancer Surgery or Radiotherapy in Exceptional Responders to Neoadjuvant Systemic Therapy
Rekruteren
- University of Pittsburgh Cancer Institute (UPCI), Pittsburgh
Signatera-Guided CDK4/6 Inhibitor Therapy in Breast Cancer
Rekruteren
- Allegheny (AHN), Pittsburgh
A Study of LY4257496 in Participants With Cancer (OMNIRAY)
RekruterenFase 1
- University of Pittsburgh Medical Center, Pittsburgh
Identifying Patterns in the Breath of Individuals With Breast Cancer
RekruterenObservatieonderzoekGezonde vrijwilligers welkom
- Weinstein Imaging Associates, Pittsburgh
Active Surveillance in Older Women With ER+ Breast Cancer
RekruterenObservatieonderzoek
- University of Pittsburgh Medical Center, Pittsburgh
A Phase I/IIa Study of AZD8205 Given Alone or Combined, in Participants With Advanced/Metastatic Solid Malignancies
RekruterenFase 1/2
- Research Site, Pittsburgh
A Study to Evaluate the Effect of GDC-4198 Alone and in Combination With Giredestrant Versus Abemaciclib and Giredestrant in Participants With Locally Advanced or Metastatic Estrogen Receptor-Positive (ER+), Human Epidermal Growth Factor Receptor-Negative (HER2-) Breast Cancer
RekruterenFase 1/2
- UPMC - Hillman Cancer Center, Pittsburgh
A Study Evaluating the Efficacy and Safety of Inavolisib Plus CDK4/6 Inhibitor and Letrozole vs Placebo + CDK4/6i and Letrozole in Participants With Endocrine-Sensitive PIK3CA-Mutated, Hormone Receptor-Positive, HER2-Negative Advanced Breast Cancer
RekruterenFase 3
- UPMC Hillman Cancer Center - Magee-Women?s Hospital, Pittsburgh
Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25
RekruterenFase 3
- Allegheny General Hospital, Pittsburgh
- UPMC-Magee Womens Hospital, Pittsburgh
- West Penn Hospital, Pittsburgh
- en nog 10
A Study With NKT5097 for Adults With Advanced/Metastatic Solid Tumors
RekruterenFase 1
- UPMC Hillman Cancer Center, Pittsburgh
A Phase 1 Study of LNCB74 in Advanced Solid Tumors
RekruterenFase 1
- UPMC, Pittsburgh
ATEMPT 2.0: Adjuvant T-DM1 vs TH
RekruterenFase 2
- University of Pittsburgh Medical Center Cancer UPMC- Magee Women's Hospital, Pittsburgh
Biennial CEM in Women With a Personal History of Breast Cancer
RekruterenGezonde vrijwilligers welkom
- Magee-Womens Hospital, Pittsburgh
- Hillman Cancer Center at Shadyside, Pittsburgh
- UPMC Magee-Womens Imaging - Bethel Park, Bethel Park · 8 mijl verwijderd
- en nog 3
EXERT-BC Cardio: Cardio or Conditioning Training With Breast Cancer
Rekruteren
- AHN Allegheny General Hospital, Pittsburgh
A Study of Izalontamab Brengitecan Versus Chemotherapy in Participants With Previously Untreated, Locally Advanced, Recurrent Inoperable, or Metastatic Triple-negative Breast Cancer Ineligible for Anti-PD(L)1 Drugs (IZABRIGHT-Breast01)
RekruterenFase 2/3
- Local Institution - 0360, Pittsburgh
E-Mindfulness Approaches for Living After Breast Cancer
RekruterenFase 3
- UPMC-Magee Womens Hospital, Pittsburgh
- UPMC-Saint Margaret, Pittsburgh
- UPMC Hillman Cancer Center, Pittsburgh
- en nog 2
Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)
RekruterenFase 1/2
- Allegheny Health Network, Pittsburgh
Testing the Safety and Efficacy of the Combination of Two Anti-cancer Drugs, ZEN003694 and Abemaciclib, for Adult and Pediatric Patients (12-17 Years) With Metastatic or Unresectable NUT Carcinoma, Breast Cancer and Other Solid Tumors
RekruterenFase 1
- UPMC Hillman Cancer Center, Pittsburgh
TeleHealth Resistance Exercise Intervention to Preserve Dose Intensity and Vitality in Elder Breast Cancer Patients
Rekruteren
- University of Pittsburgh, Pittsburgh
Safety and Tolerability of ²¹²Pb-DOTAM-GRPR1 in Adult Subjects With Recurrent or Metastatic GRPR-expressing Tumors
RekruterenFase 1
- University of Pittsburg Medical Center (UPCM), Pittsburgh
Study of CX-5461 in Patients With Solid Tumours and BRCA1/2, PALB2 or Homologous Recombination Deficiency (HRD) Mutation
RekruterenFase 1
- UPMC Hillman Cancer Center, Pittsburgh
Proteomics and Radiomics Research of Breast Cancer Markers in Tissue, Interstitial Fluid and Serum
RekruterenObservatieonderzoek
- UPMC St. Margaret, Pittsburgh
De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Equal to 18 Breast Cancer (DEBRA)
RekruterenFase 3
- Allegheny General Hospital, Pittsburgh
- West Penn Hospital, Pittsburgh
- Jefferson Hospital, Jefferson Hills · 11 mijl verwijderd
- en nog 3
A Study for CTC Expression and cfDNA/RNA Assessment in Metastatic Breast Cancer Patients
RekruterenObservatieonderzoek
- UPMC Magee Womens Hospital, Pittsburgh
The MOMENTUM Study: The Multiple Outcome Evaluation of Radiation Therapy Using the MR-Linac Study
RekruterenObservatieonderzoek
- Allegheny Health Network, Pittsburgh
EXERT-BCH Exercise Regimen to Improve Muscle Mass After Treatment of Breast Cancer
Rekruteren
- Allegheny General Hospital, Pittsburgh
Resistance Training and Post Workout Protein to Improve Body Composition During Neoadjuvant Chemotherapy for Breast Cancer
Rekruteren
- Allegheny General Hospital, Pittsburgh
EXActDNA-003 / NSABP B-64: Study of Molecular Residual Disease Detection in Breast Cancer (MRD)
RekruterenObservatieonderzoek
- UPMC Magee - Womens Hospital, Pittsburgh
The Cancer of the Pancreas Screening-5 CAPS5)Study
RekruterenFase 3
- University of Pittsburgh, Pittsburgh
MammaPrint, BluePrint, and Full-genome Data Linked With Clinical Data to Evaluate New Gene EXpression Profiles
RekruterenObservatieonderzoek
- Allegheny Health Network, Pittsburgh
- University of Pittsburgh Medical Centers, Pittsburgh
Borstkanker studies in andere steden
- New York City, NY136 studies
- Houston, TX126 studies
- Boston, MA112 studies
- Nashville, TN81 studies
- Los Angeles, CA73 studies
- Edison, NJ68 studies
- St. Louis, MO64 studies
- Queens, NY64 studies
- Durham, NC64 studies
- Chicago, IL59 studies
- Philadelphia, PA56 studies
- Dallas, TX55 studies
Andere studies in Pittsburgh
- Niet-kleincellige longkanker48 studies
- Kanker (alle vormen)41 studies
- Colorectale kanker32 studies
- Metastatische kanker31 studies
- Melanoom31 studies
- Eierstokkanker30 studies
- Endometriumkanker23 studies
- Prostaatkanker23 studies
- Longkanker23 studies
- Plaveiselcelcarcinoom van hoofd en hals22 studies
- Beroerte22 studies
- Depressie22 studies
Van ClinicalTrials.gov, gegevens opgehaald op 6 okt. 2026. Elke studie stelt eigen deelnamecriteria vast; het studieteam bepaalt wie er kan deelnemen.